Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

NCT05454787 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05454787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05454787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
June 2, 2022
Completion date
October 31, 2026
Enrollment
300 (estimated)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

factor xa inhibitor, life threatening bleeding